Previously we demonstrated that CUL4B can catalyze H2AK119 monoubiquitination and, in cooperation with PRC2, promote epigenetic silencing of tumor suppressors, leading to increased degree of malignancy [8]. The gene discussed is CUL4B; the disease is neoplasm.